Disclosure 0001814238-26-000017-1

SEC FORM 4

$5,621,692.38

Royalty Pharma plc (RPRX)

Sale of 96,073 shares at $58.5148 per share.

Reporting Person Hite Christopher · Officer Title EVP & Chairman, Partnering · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001814238-26-000017 · filed 2026-09-24 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Royalty Pharma plc (RPRX)." Disclosed 2026-09-24. https://desqlong.com/cards/0001814238-26-000017-1 (retrieved 2026-09-26).